October 1, 2010 -- Rosa & Co, a leader in both classical PK/PD modeling and trial simulation and the emerging field of physiologically-based pharmacodynamic, or PhysioPD™, modeling, is pleased to announce that Toufigh Gordi, Ph.D., has joined Rosa as President of Rosa’s PK/PD and Clinical Pharmacology Services. Dr. Gordi is an accomplished clinical pharmacologist and pharmacometrician with significant industry, academic, and consulting experience. Prior to joining Rosa, Dr. Gordi had a successful PK/PD modeling and clinical pharmacology consulting business. Before that, he was a Senior Pharmacometrician at Hoffman La Roche, and an Associate Director of pharmacokinetics at Depomed Inc. and at CV Therapeutics. Dr. Gordi holds a M.Sc. in Pharmacy and a Ph.D. in Pharmacokinetics and Pharmacodynamics from Uppsala University, Uppsala, Sweden. He completed his postdoctoral training in the laboratory of Dr. William Jusko, in the Department of Pharmaceutical Sciences, State University of New York, Buffalo.
“Adding Dr. Gordi to our staff significantly strengthens our already top-class consulting capabilities. I am honored that someone of his stature has agreed to join our team and help build our PK/PD and Clinical Pharmacology services business worldwide,” said Dr. Ron Beaver, PhD, Rosa’s Cofounder, Chairman, and CEO.
